GB0905555D0 - Pharmaceutical agent - Google Patents

Pharmaceutical agent

Info

Publication number
GB0905555D0
GB0905555D0 GBGB0905555.9A GB0905555A GB0905555D0 GB 0905555 D0 GB0905555 D0 GB 0905555D0 GB 0905555 A GB0905555 A GB 0905555A GB 0905555 D0 GB0905555 D0 GB 0905555D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical agent
pharmaceutical
agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0905555.9A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peptcell Ltd
Original Assignee
Peptcell Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptcell Ltd filed Critical Peptcell Ltd
Priority to GBGB0905555.9A priority Critical patent/GB0905555D0/en
Publication of GB0905555D0 publication Critical patent/GB0905555D0/en
Priority to PCT/EP2010/054378 priority patent/WO2010115830A2/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
    • A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GBGB0905555.9A 2009-03-31 2009-03-31 Pharmaceutical agent Ceased GB0905555D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB0905555.9A GB0905555D0 (en) 2009-03-31 2009-03-31 Pharmaceutical agent
PCT/EP2010/054378 WO2010115830A2 (en) 2009-03-31 2010-03-31 Pharmaceutical agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0905555.9A GB0905555D0 (en) 2009-03-31 2009-03-31 Pharmaceutical agent

Publications (1)

Publication Number Publication Date
GB0905555D0 true GB0905555D0 (en) 2009-05-13

Family

ID=40672044

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0905555.9A Ceased GB0905555D0 (en) 2009-03-31 2009-03-31 Pharmaceutical agent

Country Status (2)

Country Link
GB (1) GB0905555D0 (en)
WO (1) WO2010115830A2 (en)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1345964A (en) * 2000-09-29 2002-04-24 上海博德基因开发有限公司 Novel polypeptide-hexokinase 10.01 and polynucleotide for encoding said polypeptide
CN100415899C (en) * 2001-09-05 2008-09-03 普赖德普罗特奥米克斯公司 Type II diabetes protein
JP2006522816A (en) * 2003-04-11 2006-10-05 ピーアール ファーマシューティカルズ， インコーポレイテッド Method for preparing site-specific protein conjugates
FR2900342B1 (en) * 2006-04-27 2010-08-20 Cie Laitiere Europeenne USE OF ALPHA-LACTALBUMIN FOR REGULATION OF GLYCEMIA

Also Published As

Publication number Publication date
WO2010115830A2 (en) 2010-10-14
WO2010115830A3 (en) 2010-12-23

Similar Documents

Publication Publication Date Title
ZA201107776B (en) Pharmaceutical composition
GB0916335D0 (en) Medicaments
ZA201200719B (en) Pharmaceutical formulation
EP2379077A4 (en) Pharmaceutical composition
IL220526A0 (en) Kokumi-imparting agent
IL220527A0 (en) Kokumi-imparting agent
IL208953A0 (en) Pharmaceutical combination
GB0922589D0 (en) Pharmaceutical compounds
GB0920846D0 (en) Defenin inducing agent
GB0900484D0 (en) Therapeutic agent
GB0908905D0 (en) Pharmaceutical compounds
GB0916332D0 (en) Medicaments
GB0919650D0 (en) Pharmaceutical composition
GB0922537D0 (en) Pharmaceutical preparation
HU0800414D0 (en) Pharmaceutical combination
GB0905555D0 (en) Pharmaceutical agent
GB0910754D0 (en) Pharmaceutical agent
GB0920790D0 (en) Pharmaceutical agent
GB0905557D0 (en) Pharmaceutical agent
GB0913956D0 (en) Pharmaceutical agent
GB0905558D0 (en) Pharmaceutical agent
GB0910772D0 (en) Pharmaceutical
GB0916458D0 (en) Pharmaceutical compounds
GB0922523D0 (en) Pharmaceutical compounds
GB0917677D0 (en) Pharmaceutical compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)